CAPLIPOINT

Caplin Point Laboratories Share PriceCaplin Point Laboratories

₹761.5
4.75 (0.63%)
As on 02 June, 2023 | 18:32 BSE: 524742 NSE: CAPLIPOINT

Caplin Point Laboratories Performance

Day Range

  • Low
  • High
761.5

52 Week Range

  • Low
  • High
761.5
  • Open Price
  • Previous Close
  • Volume

Start SIP in Caplin Point Laboratories

Start SIP

Caplin Point Laboratories Share Price

  • Over 1 Month 11.21%
  • Over 3 Month 16.11%
  • Over 6 Month 0.06%
  • Over 1 Year 0.73%

Caplin Point Laboratories Key Statistics

P/E Ratio 15.4
PEG Ratio 0.6
Market Cap Cr 5,781
Price to Book Ratio 3
EPS 30.9
Dividend 0.3
Relative Strength Index 76.87
Money Flow Index 80.51
MACD Signal 20.53
Average True Range 20.27

Caplin Point Laboratories Investment Rating

  • Master Rating:
  • Caplin Point Labs. has an operating revenue of Rs. 1,466.73 Cr. on a trailing 12-month basis. An annual revenue growth of 16% is outstanding, Pre-tax margin of 31% is great, ROE of 20% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is comfortably placed above its key moving averages, around 13% and 6% from 50DMA and 200DMA. It is currently FORMING a base in its weekly chart and is trading around 11% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 93 which is a GREAT score indicating consistency in earnings, a RS Rating of 53 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 103 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Caplin Point Laboratories Financials
IndicatorMar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 145131137116112
Operating Expenses Qtr Cr 8079807074
Operating Profit Qtr Cr 6552574638
Depreciation Qtr Cr 66767
Interest Qtr Cr 00000
Tax Qtr Cr 1615161113
Net Profit Qtr Cr 5459586329

Caplin Point Laboratories Technicals

EMA & SMA

Current Price
₹761.5
4.75 (0.63%)
  • Bullish Moving Average
  • ___
  • 16
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • ₹721.52
  • 50 Day
  • ₹693.19
  • 100 Day
  • ₹689.06
  • 200 Day
  • ₹701.49
  • 20 Day
  • ₹718.71
  • 50 Day
  • ₹668.75
  • 100 Day
  • ₹676.94
  • 200 Day
  • ₹710.21

Caplin Point Laboratories Resistance and Support

PIVOT
₹761.4
Resistance
First Resistance ₹777.55
Second Resistance ₹798.35
Third Resistance ₹814.5
RSI 76.87
MFI 80.52
MACD Single Line 20.53
MACD 22.99
Support
First Resistance ₹740.6
Second Resistance ₹724.45
Third Resistance ₹703.65

Caplin Point Laboratories Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 268,422 6,562,918 24.45
Week 136,687 5,410,064 39.58
1 Month 95,622 3,973,081 41.55
6 Month 83,228 3,639,551 43.73

Caplin Point Laboratories Result Highlights

Caplin Point Laboratories Synopsis

NSE-Medical-Generic Drugs

Caplin Point Lab is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 528.61 Cr. and Equity Capital is Rs. 15.18 Cr. for the Year ended 31/03/2023. Caplin Point Laboratories Ltd. is a Public Limited Listed company incorporated on 16/04/1990 and has its registered office in the State of Tamil Nadu, India. Company’s Corporate Identification Number(CIN) is L24231TN1990PLC019053 and registration number is 019053.
Market Cap 5,790
Sales 529
Shares in Float 2.20
No of funds 77
Yield 0.53
Book Value 5.04
U/D Vol ratio 1.7
LTDebt / Equity
Alpha
Beta 0.76

Caplin Point Laboratories

Owner NameMar-23Dec-22Sep-22Jun-22
Promoters 70.66%68.8%68.88%68.88%
Mutual Funds 0.57%1.04%1.05%1.06%
Foreign Portfolio Investors 2.36%2.24%2.15%2.03%
Financial Institutions/ Banks
Individual Investors 18.73%18.91%19%20.77%
Others 7.68%9.01%8.92%7.26%

Caplin Point Laboratories Management

Name Designation
Mr. C C Paarthipan Chairman
Dr. Sridhar Ganesan Managing Director
Mr. V Thirumalai Independent Director
Mr. R Viswanathan Independent Director
Mr. D Sathyanarayanan Independent Director
Dr. C K Gariyali Independent Director

Caplin Point Laboratories Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Caplin Point Laboratories Corporate Action

Date Purpose Remarks
2023-05-27 Audited Results & Interim Dividend (Revised) per share(100%)Dividend
2023-02-11 Quarterly Results
2022-11-12 Quarterly Results
2022-08-05 Quarterly Results & Final Dividend
2022-05-12 Audited Results & Interim Dividend
Date Purpose Remarks
2023-06-09 FINAL Rs.2.00 per share(100%)Interim Dividend
2022-05-24 INTERIM Rs.2.00 per share(100%)Interim Dividend
2021-05-19 INTERIM Rs.1.50 per share(75%)Interim Dividend

Caplin Point Laboratories MF Shareholding

Name Amount(cr)
Quant Small Cap Fund Growth 4092
Quant Tax Plan Growth 3533
Nippon India Nifty Smallcap 250 Index Fund Reg Gr 428
Motilal Oswal Nifty 500 Fund Regular Growth 418
Motilal Oswal Nifty Smallcap 250 Index Fund Regular Growth 341

Caplin Point Laboratories FAQs

What is Share Price of Caplin Point Laboratories ?

Caplin Point Laboratories share price is ₹761 As on 02 June, 2023 | 18:18

What is the Market Cap of Caplin Point Laboratories ?

The Market Cap of Caplin Point Laboratories is ₹5781.4 Cr As on 02 June, 2023 | 18:18

What is the P/E ratio of Caplin Point Laboratories ?

The P/E ratio of Caplin Point Laboratories is 15.4 As on 02 June, 2023 | 18:18

What is the PB ratio of Caplin Point Laboratories ?

The PB ratio of Caplin Point Laboratories is 3 As on 02 June, 2023 | 18:18

Q2FY23

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number